In our fourth Pride Month podcast episode, we are speaking with Domenico Ruggerio, executive director of We Are Family, in Charleston, South Carolina, the state's oldest nonprofit to provide life-affirming and life-saving programs for lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) youth.
We Are Family, headquartered in Charleston, South Carolina, is the state's oldest nonprofit to provide LGBTQ+ services; it was founded by Tom Meyers who noticed the lack of supportive services for his gay son and local LGBTQ+ youth | Image Credit: We Are Family
Welcome to another episode of Managed Care Cast and the fourth podcast in our series to celebrate Pride Month in 2024. Today we are speaking with Domenico Ruggerio, executive director of We Are Family, in Charleston, South Carolina, which was founded in 1995 and provides life-affirming and life-saving programs for lesbian, gay, bisexual, transgender, queer plus (LGBTQ+) youth, up to the age of 24, by upholding 5 core values: imagination, celebration, self-determination, intersectional justice, and education of self and others.
In our conversation, we hit on the importance of mental health services for LGBTQ+ youth, and how the pandemic and social media have collided to show how necessary these services are; the many other social support and health and wellness programs that We Are Family provides; and, as with our earlier episodes, health care policy priorities for the LGBTQ+ community in this election year.
And please check out our earlier episodes with Lancaster Pride, Rutgers, and Callen-Lorde.
Listen above or through one of these podcast services:
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More